ArticleInternational journal of molecular sciences2022

The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines.

Yixuan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.